Revere Pharmaceuticals

Arlington, United States

Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants.

$1.1M raised

Sep 2021

Venture - Series Unknown

Biopharma Biotechnology Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Revere Pharmaceuticals

How much funding has Revere Pharmaceuticals raised?

Revere Pharmaceuticals has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.

Where is Revere Pharmaceuticals headquartered?

Revere Pharmaceuticals is headquartered in Arlington, United States.

What does Revere Pharmaceuticals do?

Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants.

What stage is Revere Pharmaceuticals at?

Revere Pharmaceuticals is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 1, 2021.

MLA

"Revere Pharmaceuticals — Funding & Investors." VCBacked, September 1, 2021, https://www.vcbacked.co/company/revere-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2021). Revere Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/revere-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Revere Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/revere-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 1, 2021.